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Pediatric liver disorders constitute a major burden of hospital admissions. Liver function tests are one of the common routine biochemical evaluations done 
in patients with suspicion of liver disease. Among these, the 
aminotransferases (formerly transaminases) are the most 
sensitive biomarkers of hepatocyte integrity. Aminotransferases 
are intracellular enzymes produced mainly by the hepatocytes. 
They are normally present in serum at low levels and 
increase in their levelss suggests liver injury [1,2]. Aspartate 
aminotransferase (AST), previously known as serum glutamic 
oxaloacetic transaminase is widely distributed throughout 
the body. Besides liver, it is also present in cardiac and 
skeletal muscles, kidney, brain, pancreas, lung, leukocytes 
and erythrocytes, and in decreasing order of concentration. 
Alanine aminotransferase (ALT) or serum glutamate pyruvate 
transaminase is mainly present in liver thus more specific to liver 
disease [3,4]. While AST is present in both the mitochondria 
and cytosol of hepatocytes as two separate isoenzymes, ALT is 
localized to the cytosol [2-4].
Normal values of aminotransferases used in children vary 
among laboratories as reference pediatric standards have not 
been fully established. England et al. have proposed ALT 
centiles for age and sex based on a study in healthy European 
population [5]. They proposed an ALT upper limit of normal 
(ULN) of 60 IU/L in boys and 55 IU/L in girls during the first 
18 months of life and 40 IU/L in boys and 35 IU/L in girls after 
the age of 18 months [5]. The screening ALT for elevation in 
Today’s Youth (SAFETY) study conducted on a population of 
North American patients aged between 12 and 17 years shows 
that the ULN used by the most laboratories for ALT is too high to 
detect chronic liver disease [6].
Complete assessment of enzyme abnormalities involves 
careful evaluation of the predominant pattern of enzyme 
alteration, the magnitude alteration in aminotransferases, the 
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rate of change and the nature of the course of alteration [4]. 
The magnitude of enzyme elevation has been arbitrarily divided 
into mild (1-3 times ULN), moderate (3-20 times ULN), and 
severe (>20 times ULN, >1000 U/ml) types [3]. However, this 
classification is arbitrary as no standard definition exists. There 
are only a few studies on the approach to hypertransaminasemia 
in children with liver disease; especially, in a hospital setting. 
Through this study, we tried to analyze the data of hospitalized 
children with raised aminotransferases; thereby, understanding 
their spectrum of clinical presentation and correlate etiology with 
their severity level.
MATERIALS AND METHODS
This study was an observational retrospective study conducted in 
the Department of Paediatric Medicine, SMS Medical College, 
Jaipur. The study was conducted on 65 admitted children of age 
group, 1 month to 18 years with raised aminotransferase levels 
during 1st January 2015-31st July 2015. The hospital records of 
these patients were reviewed. All the detailed history, blood 
investigations, and radiological findings were noted. Full 
liver function test with prothrombin time (PT) international 
normalized ratio (INR) was analyzed. On the basis ALT levels, 
these patients were divided into three groups as mild (1-3 times 
of normal), moderate (3-20 times of normal), and severe if ALT 
≥20 times [3]. The normal level of AST and ALT of our institute 
laboratory is 0-37 IU/L and 0-42 IU/L, respectively.
Based on the clinical picture and liver function tests, patients 
were divided into various groups such as acute hepatitis, acute 
liver failure, and chronic liver disease. Acute liver failure and 
acute on chronic liver failure were defined as per the following 
definitions.
Acute liver failure: (1) No evidence of a known chronic 
liver disease, (2) hepatic-based coagulopathy that is not 
corrected by parenteral administration of vitamin K, (3) hepatic 
encephalopathy must be present if the uncorrected PT or INR was 
between 15 and 19.9 s or 1.5-1.9, respectively; and (4) hepatic 
encephalopathy was not required if the PT or INR was ≥20s or 
2.0, respectively [7].
Acute on chronic liver failure (Asian Pacific Association 
for the Study of the Liver Guidelines): Acute hepatic insult 
manifesting as jaundice (serum bilirubin ≥5 mg/dl [85 μmol/l]) 
and coagulopathy (INR ≥1.5 or prothrombin activity <40%), 
complicated within 4 weeks by ascites and/or encephalopathy in 
a patient with previously diagnosed or undiagnosed chronic liver 
disease [8].
The etiological diagnoses of these patients were noted. To 
ascertain the etiology in these patients our institutional protocol 
was as follows. We conduct infective workup and ultrasonography 
(USG) abdomen in each patient. Infective workup includes viral 
markers (hepatitis B surface antigen, hepatitis C virus antibody, 
hepatitis E virus immunoglobulin M [IgM], and hepatitis A virus 
IgM), malaria antigen, widal, and blood culture. USG abdomen 
with Doppler is performed to see the liver echotexture, signs 
of portal hypertension, biliary tract obstruction, and vascular 
obstructions.
Other specific investigations such as autoimmune workup 
(immunoglobulin G levels, Antinuclear antibody, anti-liver 
kidney microsomal antibodies, SMS antibody, etc., with liver 
histopathology), Wilson’s disease workup (serum ceruloplasmin, 
24 h urinary copper, slit lamp examination for Kayser-Fleischer 
Ring), and metabololic workup (blood gas analysis, tandem 
mass spectroscopy, serum lactate levels, urine reducing 
substance, urine succinylacetone, and histopathology of liver) 
are done according to the clinical scenario and standard practice 
guidelines to ascertain the etiology as and when required. 
Computerized tomography (CT) triphasic angio abdomen is 
done in suspected patients of Budd-Chiari syndrome. Magnetic 
resonance cholangiopancreatography is done in suspected cases 
of choledochal cyst. Diagnosis of extrahepatic biliary atresia 
is made on the basis of clinical presentation, USG abdomen, 
hepatobiliary iminodiacetic acid scan, and liver biopsy.
Compilation of data was done in Microsoft Excel 2010 
spreadsheet, and percentage analysis was performed. The 
OpenEpi software was used for statistical analysis [9]. The 
correlation of the severity level with the etiology was done using 
simple statistical methods. Data were analyzed using descriptive 
statistics. p<0.05 was considered significant.
RESULTS
Total number of patients studied was 65, out of which 39 were male. 
The mean age was 72±52 months (range 1 month - 18 years). Out 
of 65 children, 35 (53%) had acute hepatitis, 15 (23%) acute liver 
failure, 7 (10%) acute on chronic liver failure, and 8 (12%) patients 
had chronic liver disease. Their etiological diagnosis based on 
appropriate investigations is noted and presented in Table 1. Their 
ALT levels were raised in the range of 50-3489 IU/L (normal 
range 0-42 IU/L). Mild elevation of ALT was seen in 17 (26%) 
patients with mean levels of 78.8±27 IU/L (range 50-117 IU/L). 
The etiologies for mild elevation were metabolic (6), extrahepatic 
obstruction (4), infective hepatitis (3), autoimmune hepatitis (2), 
diabetic ketoacidosis (1), and cryptogenic (1). The extrahepatic 
obstruction was due to extrahepatic biliary atresia (EHBA) in 3 
and choledochal cyst in 1 case (Table 2).
Moderate elevation of ALT was seen in 24 (37%) patients with 
mean levels of 289±153 IU/L (range 124-686 IU/L). Moderate 
elevation was due to following etiologies: Infective hepatitis (7), 
metabolic (4), EHBA (3), neonatal hepatitis (2), ischemic (2), 
autoimmune hepatitis (2), HLH (2), cryptogenic (1), and drug-
induced (1). The infective causes were due to viral hepatitis (2), 
sepsis (2), enteric fever (2), and malaria (1). Ischemic causes were 
due to congestive cardiac failure (1) and Budd-Chiari syndrome (1). 
Severe elevation of ALT was seen in 24 (37%) patients with 
mean levels of 1938±861 IU/L (range - 840-3489 IU/L). The 
most common etiological diagnosis was infective hepatitis in 
17 (70%), followed by ischemic (5), autoimmune hepatitis (1), 
and drug-induced (1). Infective hepatitis was due to viral hepatitis 
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(13), sepsis (3), and falciparum malaria (1). Ischemic causes were 
due to shock (4) and Budd-Chiari syndrome (1) (Table 2).
Out of 27 acute infective hepatitis patients, 19 (70.4%) had 
viral hepatitis, 2 (7.4%) had severe falciparum malaria, 2 (7.4%) 
patients had enteric fever, and sepsis was present in 4 patients 
(14.81%). Out of 10 metabolic liver disease, 4 (40%) were 
Wilson disease, 3(30%) were hereditary tyrosinemia Type 1, and 
1 (10%) were glycogen storage disease, and 2 (20%) cases were 
of suspected mitochondrial disease (Table 1).
Acute infective hepatitis had the most severe degree of 
enzyme elevation seen in 63% (17) of these patients while mild to 
moderate elevation was seen in 37% (10) of this group, (p<0.05). 
All the patients of metabolic liver disease and extrahepatic 
biliary obstruction had only mild to moderate elevation of 
aminotransferases (p<0.001), (Table 3). Of the 15 cases presenting 
with acute liver failure, the most common cause was hepatitis A. 
AST/ALT ratio was calculated for different etiology. We found 
that 60% of autoimmune hepatitis, 50% of acute viral hepatitis, 
and 50% EHBA had AST/ALT <1. The ratio was more than two 
for 42% of ischemic hepatitis, and 50% of drug-induced hepatitis. 
Patients with Wilson disease (WD) who presented in acute liver 
failure had AST/ALT >4.
DISCUSSION
Liver diseases in children represent a significant problem with 
a major impact on public health. No data are available on the 
prevalence of liver diseases in children; especially, in developing 
countries. In unites states, about 15,000 children are admitted 
each year with liver diseases [10]. In our study, the most common 
presentation of hepatobiliary disease was acute hepatitis in 54% 
of the patients while the chronic liver disease was seen in 12.3% 
patients. A similar study by Yachha et al. has reported acute 
hepatitis in 28% and chronic liver disease in 36% of admitted 
children in North India [11]. Very few studies are available from 
this region of the world to shed light on the prevalence of chronic 
liver disease. The prevalence of chronic liver disease in our study 
was 23.1% including the acute on chronic liver disease; which is 
slightly less than the prevalence (36%) reported previously [11]. 
Metabolic liver disease was seen in 15.4% of our patients, which 
was similar to the figure of 16% in other North Indian hospital 
setting [11].
Alterations in liver enzyme levels that are encountered vary 
by the geographical location of the hospitals and the ethnicity of 
the patients. 60% of the cases of elevated hepatic AST levels in 
developed countries can be attributed to ischemic or toxic liver 
injury [12], whereas oro-fecal transmittable hepatitis viruses are 
the major cause (>60%) of sporadic acute and fulminant hepatitis 
in the developing countries [13-15]. Among the infective causes, 
hepatitis A was the most common cause of acute hepatitis in 
children in our study (41%).
Table 1: Clinico-etiological profile of study population (n=65)
Etiological diagnosis Number of patients
Acute infective hepatitis (n=27)
Acute viral hepatitis 19
Sepsis 4
Falciparum malaria 2
Enteric hepatitis 2
Metabolic liver disease (n=10)
WD 4
Hereditary tyrosinemia type 1 3
Glycogen storage disease 1
Suspected mitochondrial disease 2
Biliary tract obstruction (n=7)
Extrahepatic biliary atresia 6
Choledochal cyst 1
Ischemic (n=7)
Septic shock 4
Acute Budd-Chiari syndrome 2
Cardiogenic shock 1
Autoimmune hepatitis 5
Neonatal hepatitis 2
HLH 2
Drug induced 2
Cryptogenic 2
Diabetic ketoacidosis 1
WD: Wilson disease, HLH: Hemophagocytic lymphohistiocytosis
Table 2: Etiological profile of deranged aminotransferases according to severity level
Mild elevation Moderate elevation Marked elevations
(1-3 times), (n=17) (3-20 times), (n=24) (>20 times), (n=24)
EHBA 3 Infective hepatitis 7 Acute viral hepatitis 13
Choledochal cyst 1 Autoimmune hepatitis 2 Ischemic 5
Infective hepatitis 3 EHBA 3 Sepsis 3
Hereditary tyrosinemia 3 Neonatal hepatitis 2 Falciparum malaria 1
Autoimmune hepatitis 2 WD 2 Autoimmune hepatitis 1
GSD type III 1 Ischemic 2 Drug induced 1
WD 2 Suspected mitochondrial liver disease 2
Diabetic ketoacidosis 1 HLH 2
Cryptogenic 1 Drug induced 1
Cryptogenic 1
WD: Wilson disease, EHBA: Extrahepatic biliary atresia, GSD: Glycogen storage disease, HLH: Hemophagocytic lymphohistiocytosis
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Patients with a marked increase in aminotransferase levels 
more than 10 times the upper reference limits typically have an 
acute hepatic injury. The degree of elevation varies during the 
course of injury and depends on when the enzyme levels were 
tested. Patients with acute viral or ischemic or toxic liver injury 
reach the highest aminotransferase levels [4]. Similarly, our 
study showed that the most common cause of marked elevation 
of aminotransferases was acute viral hepatitis (70%) followed 
by ischemic injury (20%). Very high aminotransferase levels of 
more than >75 times the upper reference limits indicate ischemic 
or toxic liver injury in more than 90% of cases of acute hepatic 
injury, whereas they are less commonly observed with acute viral 
hepatitis [4]. Autoimmune hepatitis may present with a mild to 
marked increase in aminotransferase levels [4,16]. In our study, 
40% of autoimmune hepatitis showed mild elevation, while 60% 
showed moderate to severe elevation of aminotransferases.
ALT exceeds AST in viral hepatitis, autoimmune hepatitis, 
chronic active hepatitis, and cholestatic hepatitis [3]. In our study, 
60% of the autoimmune hepatitis, 50% of acute viral hepatitis, 
50% EHBA had AST/ALT ratio less than one. In ischemic or toxic 
liver injury, AST levels usually peak before those of ALT because 
of the enzyme’s peculiar intralobular distribution [17]. Zone three 
of the acinus is more vulnerable to both hypoxic (hepatocytes are 
exposed to an already oxygen-poor milieu) and toxic (hepatocytes 
are richer in microsomal enzymes) damage. Ischemic and hypoxic 
acute liver damage is more likely in patients with concomitant 
clinical conditions such as sepsis or low-flow hemodynamic 
state [12,17,18]. Our study showed 42% of ischemic hepatitis and 
50% of drug-induced hepatitis with AST/ALT >2.
WD is a leading cause of metabolic and chronic liver disease 
in children [19]. The ratio of AST to ALT of more than two is 
usually observed in WD [20]. In acute liver failure due to WD, 
the serum AST level may be higher than the serum ALT level, 
potentially reflecting mitochondrial damage, but this finding is 
not sufficiently invariable to be diagnostic [19,20]. In our study, 
two patients of WD presented with acute liver failure with AST/
ALT ratio more than two.
Only a few studies have documented the results of a thorough 
evaluation of patients with mildly elevated aminotransferases 
levels in children. Fatty liver, resulting either from alcohol use 
or from nonalcoholic fatty liver disease, is the major cause of 
mildly elevated aminotransferases in adults [4]. In our study, 
the metabolic liver disease was most common cause of mild 
elevation followed by extrahepatic obstruction. Nonalcoholic 
steatohepatitis and celiac disease are one of the common causes 
of mild elevation of ALT levels [3,4], which were not found in our 
study probably because the study was conducted only in admitted 
patients.
There were few limitations in this study. The study was 
a retrospective study conducted on admitted patients only; 
outpatients were not included in this study. The management and 
outcome of patients were not included.
CONCLUSIONS
Alterations in liver enzyme levels are one of the most common 
problems encountered in everyday clinical practice. These 
are a sensitive indicator of hepatocyte damage and are thus 
particularly useful in the early detection of viral hepatitis and 
in monitoring its progress. The pattern of enzyme abnormality, 
interpreted in the context of the patient’s characteristics, can aid 
in directing the subsequent diagnostic workup. Awareness of the 
prevalence of determined liver disease in specific populations 
and of possible hepatic involvement during systemic illnesses 
or drug therapies may help the clinician identify the cause of 
alterations efficiently.
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